[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Budesonide Market Survey and Trend Research 2018

December 2017 | 83 pages | ID: G1545485376EN
99Strategy

US$ 2,600.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and nasal spray.The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The nasal spray is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis.

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain
  • Raw Materials
  • Cost
  • Technology
  • Consumer Preference
Industry Overall:
  • History
  • Development & Trend
  • Market Competition
  • Trade Overview
  • Policy
Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):
  • Regional Market
  • Production Development
  • Sales
  • Regional Trade
  • Regional Forecast
Company (AstraZeneca, Cosmo Pharmaceuticals, Teva, Mylan, Dr. Falk Pharma, Dr. Falk Pharma, Chiesi Farmaceutici S.p.A, Orion Corporation, Cipla, Synmosa Biopharma Corporation, Lunan Better Pharmaceutical, Shanghai Sine Promod Pharmaceutical etc.):
  • Company Profile
  • Product & Service
  • Business Operation Data
  • Market Share
Investment Analysis:
  • Market Features
  • Investment Opportunity
  • Investment Calculation
PART 1 INDUSTRY OVERVIEW

1.1 Budesonide Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 BUDESONIDE MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 AstraZeneca (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Cosmo Pharmaceuticals (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Teva (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Mylan (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Dr. Falk Pharma (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Dr. Falk Pharma (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Chiesi Farmaceutici S.p.A (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Orion Corporation (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Cipla (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Synmosa Biopharma Corporation (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Lunan Better Pharmaceutical (Company Overview, Sales Data etc.)
4.12 Shanghai Sine Promod Pharmaceutical (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

LIST OF TABLES

Table Global Budesonide Market 2012-2017, by Type, in USD Million
Table Global Budesonide Market 2012-2017, by Type, in Volume
Table Global Budesonide Market Forecast 2018-2023, by Type, in USD Million
Table Global Budesonide Market Forecast 2018-2023, by Type, in Volume
Table AstraZeneca Overview List
Table Budesonide Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cosmo Pharmaceuticals Overview List
Table Budesonide Business Operation of Cosmo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Overview List
Table Budesonide Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mylan Overview List
Table Budesonide Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dr. Falk Pharma Overview List
Table Budesonide Business Operation of Dr. Falk Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dr. Falk Pharma Overview List
Table Budesonide Business Operation of Dr. Falk Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Chiesi Farmaceutici S.p.A Overview List
Table Budesonide Business Operation of Chiesi Farmaceutici S.p.A (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Orion Corporation Overview List
Table Budesonide Business Operation of Orion Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cipla Overview List
Table Budesonide Business Operation of Cipla (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Synmosa Biopharma Corporation Overview List
Table Budesonide Business Operation of Synmosa Biopharma Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Lunan Better Pharmaceutical Overview List
Table Budesonide Business Operation of Lunan Better Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Shanghai Sine Promod Pharmaceutical Overview List
Table Budesonide Business Operation of Shanghai Sine Promod Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Budesonide Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Budesonide Sales Revenue Share, by Companies, in USD Million
Table Global Budesonide Sales Volume 2012-2017, by Companies, in Volume
Table Global Budesonide Sales Revenue Share, by Companies in 2017, in Volume
Table Budesonide Demand 2012-2017, by Application, in USD Million
Table Budesonide Demand 2012-2017, by Application, in Volume
Table Budesonide Demand Forecast 2018-2023, by Application, in USD Million
Table Budesonide Demand Forecast 2018-2023, by Application, in Volume
Table Global Budesonide Market 2012-2017, by Region, in USD Million
Table Global Budesonide Market 2012-2017, by Region, in Volume
Table Budesonide Market Forecast 2018-2023, by Region, in USD Million
Table Budesonide Market Forecast 2018-2023, by Region, in Volume

LIST OF FIGURES

Figure Budesonide Industry Chain Structure
Figure Global Budesonide Market Growth 2012-2017, by Type, in USD Million
Figure Global Budesonide Market Growth 2012-2017, by Type, in Volume
Figure Global Budesonide Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Budesonide Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region


More Publications